反应 #1851990

ord-3437520e0faa452f8c21f0eda9c0209c

反应方程式

CCOC(=O)N1CC[C@H]2[C@@H](C1)c1cccc3c1N2CC(=O)N3
material
CCOC(=O)N1CC[C@H]2[C@@H](C1)c1cccc3c1N2CC(=O)N3
ethyl (6bR,10aS)-2-oxo-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate
CCI
ethyl iodide
CCN1CCN2c3c(cccc31)[C@@H]1CNCC[C@@H]12
title compound
CCN1CCN2c3c(cccc31)[C@@H]1CNCC[C@@H]12
(6bR,10aS)-3-ethyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline

反应条件

详细条件
See reaction.notes.procedure_details.

实验过程

Utilizing the material from Example 255 Step A, the title compound was prepared in analogous fashion using ethyl iodide as the alkyl halide and following the procedure of Step B-D of Example 255, as a light brown amorphous solid. 1H NMR (CDCl3, 300 MHz) δ 1.15 (t, 3H), 1.70-2.01 (m, 3H), 2.65-2.70 (t, J=9.6 Hz, 3H), 2.70-2.95 (m,2H), 2.95-3.13 (m, 2H), 3.13-3.72 (m, 5H), 3.60-3.95 (m, 1H), 6.39 (d, J=8.0 Hz, 1H), 6.47 (d, J=7.4 Hz, 1H), 6.64 (t, J=7.3 Hz), 1H) ppm. MS (CI): 244 (M+H+).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: USRE039680E1uspto-grants-2007_06